A Randomised, Double-Blind, Placebo-Controlled Study to Determine the Pharmacokinetics, Safety and Tolerability of AZD7295 Capsules in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2010
At a glance
- Drugs AZD 7295 (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 06 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2010 Planned end date changed from 1 Sep 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 03 May 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.